“Navigating Regulatory and Supply Chain Challenges Today and Tomorrow” was the topic of the May 16 NCBIO Medical Device Luncheon and Forum held at the N.C Biotechnology Center.
The discussion was moderated by Eric Hill, senior director, scientific and technical services for Boston Analytical. The event was sponsored by Clancy & Theys Construction Company, Hughes Pittman & Gupton, Mercury Business Services, UniClean Cleanroom Services and YourBio Health.
To start off, the panelists gave an overview of what was currently happening and most relevant to them in their working environment.Read More
Panelists at the NCBIO Emerging Companies Luncheon and Forum held Wednesday, March 22, at the NC Biotechnology Center offering insight into the way their organizations choose investments, when to seek SBIR funding, engaging with a funding agency for the first time and more.
The forum was sponsored by Clancy & Theys Construction Company, JBK Associates International, Nikon and SAS.
The panel was moderated by Kseniya Simpson, Ph.D., associate, Hatteras Venture Partners.Read More
At the March 15 meeting the NCBIO Biomanufacturers Forum, attendees received updates on the $25 million Build Back Better Regional Challenge grant awarded in the fall. In September, a statewide coalition of public and private partner organizations and institutions led by NC Biotech and including NCBIO received the award from the U.S. Economic Development Administration’s Build Back Better Regional Challenge. The grant will support a number of life sciences workforce initiatives collectively called Accelerate NC.Read More
Approximately 300 NCBIO member representatives and North Carolina law makers came together Wednesday, March 1, at the NCBIO Legislative Reception held at the NC Museum of History in Raleigh.Read More
With a significant gift from Amgen, NCBIO has reached its goal of raising $250,000 to create a scholarship fund at the NC Community College Foundation for students pursuing degrees and certifications in the life sciences. The total amount of gifts and pledges now stands at approximately $260,000.Read More
An expert panel explored the current state of clinical trial participation at the NCBIO Clinical Research Forum held Tuesday, Nov. 29. Panelists talked about ways to lower the barriers that stop patients from participating in clinical trials and discussed strategies for achieving diversity. They also explored the role of patient advocates and gave special consideration to efforts focused on rare diseases.Read More
The 2022 NCBIO Annual Meeting held Oct. 12 at the NC Biotechnology Center featured expert panels on locating in North Carolina, talent recruitment, financial trends and health equity and disparities. The meeting returned to being fully in person this year after several years of being virtual or offering an online option due to the COVID pandemic.Read More
In this past year, we emerged from the isolation of COVID-19 thanks in no small part to the heroic work of the life sciences industry in developing vaccines, rapid tests and new treatments that have made the pandemic much more manageable. In spite of this success, we have faced tremendous pressure at the federal level with threats to intellectual property, the lifeblood of the industry, and a push to insert price controls with potential repercussions on innovation.Read More
Sen. Richard Burr reflected on his 28-year career in Congress and discussed FDA reform, the nation’s response to future pandemics and the pitfalls of the nation’s regulatory system at the 2022 NCBIO Annual Dinner held Monday, Oct. 10, at the NC Biotechnology Center.Read More
Donald Thompson, founder and CEO of The Diversity Movement, spoke to NCBIO members about “Critical Conversations in the Workplace” in a Sept. 14 online forum. The event recording is available on NCBIO’s YouTube channel. “The points of view and perspectives that people have are driven by their experiences for sure, but they’re also driven by…Read More